The Food and Drug Administration (FDA) now requires that all clinical trials for drugs that affect the central nervous systemincluding psychiatric drugsare assessed for whether that drug might cause suicidal ideation or behavior. The Institute of Medicine’s (IOM) Forum on Neuroscience and Nervous System Disorders hosted a meeting on June 26, 2009, to discuss the FDA’s new policy and how to analyze best whether suicidal thoughts predict actual suicidal behavior in the near future.
€21.12
购买此电子书可免费获赠一本！
语言 英语 ● 格式 PDF ● 网页 88 ● ISBN 9780309148849 ● 编辑 Bruce Altevogt & Miriam Davis ● 出版者 National Academies Press ● 发布时间 2010 ● 下载 3 时 ● 货币 EUR ● ID 7141514 ● 复制保护 Adobe DRM
需要具备DRM功能的电子书阅读器
来自同一作者的更多电子书 / 编辑
33,031 此类电子书
